{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Investigational
Source:
INN:eldocasiran [INN]
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Class:
NUCLEIC ACID
Status:
Investigational
Source:
INN:doruxapapogene ralaplasmid [INN]
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Source:
INN:rapirosiran [INN]
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Class:
NUCLEIC ACID
Status:
Investigational
Source:
USAN:LEPODISIRAN SODIUM [USAN]
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Source:
USAN:IMDUSIRAN SODIUM [USAN]
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Source:
NCT01490879: Phase 2 Interventional Completed Diabetic Foot Ulcers
(2012)
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Source:
INN:rondaptivon pegol [INN]
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Class:
NUCLEIC ACID